Modai I, Apter A, Golomb M, Wijsenbeek H
Neuropsychobiology. 1979;5(4):181-4. doi: 10.1159/000117681.
This investigation was done in order to test the hypothesis that urinary MHPG levels provide a predictor of response to therapy in depressed patients. 15 elderly biopolar depressives were included in this study. Their depressive state was estimated by the Hamilton Depressive Scale and their urinary MHPG levels were simultaneously measured before and after 5 weeks of amitriptyline therapy. When comparing amitriptyline responders to nonresponders by parametric techniques, the responders excreted significantly higher mean MHPG levels before the treatment than the nonresponders. During treatment MHPG levels rose significantly in both groups.
进行此项研究是为了验证尿中3-甲氧基-4-羟基苯乙二醇(MHPG)水平可作为抑郁症患者治疗反应预测指标的假设。本研究纳入了15名老年双相抑郁症患者。采用汉密尔顿抑郁量表评估他们的抑郁状态,并在阿米替林治疗5周前后同时测量其尿中MHPG水平。运用参数技术比较阿米替林治疗反应者与无反应者时,治疗前反应者排泄的平均MHPG水平显著高于无反应者。治疗期间两组的MHPG水平均显著升高。